Molineaux Christopher 4

4 · Calithera Biosciences, Inc. · Filed Dec 6, 2017

Form 4

Period: 2017-12-05

SR. VP, DEVELOPMENT

Transactions

Exercise/Conversion
Common Stock
2017-12-05$0.96/sh+6,502$6,242→ 9,002 total
Exercise/Conversion
Employee Stock Option (Right to Buy)
2017-12-05−2,700→ 6,006 total
Exercise: $2.64Exp: 2023-12-16→ Common Stock (2,700 underlying)
Exercise/Conversion
Employee Stock Option (Right to Buy)
2017-12-05−5,300→ 34,030 total(indirect: By Spouse)
Exercise: $2.64Exp: 2023-12-16→ Common Stock (5,300 underlying)
Exercise/Conversion
Employee Stock Option (Right to Buy)
2017-12-05−6,502→ 0 total
Exercise: $0.96Exp: 2023-05-22→ Common Stock (6,502 underlying)
Exercise/Conversion
Employee Stock Option (Right to Buy)
2017-12-05−7,568→ 0 total(indirect: By Spouse)
Exercise: $0.96Exp: 2023-05-22→ Common Stock (7,568 underlying)
Exercise/Conversion
Common Stock
2017-12-05$2.64/sh+2,700$7,128→ 11,702 total

Holdings

Footnotes (4)

[F1]Includes 2,500 shares acquired under the Company's 2014 Employee Stock Purchase Plan on June 9, 2017.
[F2]Shares are held by the Molineaux Family Trust, of which the Reporting Person is a Trustee, including 12,044 shares transferred from the Reporting Person to the Molineaux Family Trust on March 30, 2017.
[F3]1/48 of the Option vests in equal monthly installments one month from 05/23/2013. The option shall be subject to accelerated vesting as set forth in the optionee's employment agreement with the Company.
[F4]1/48 of the Option vests in equal monthly installments one month from 12/17/2013. The option shall be subject to accelerated vesting as set forth in the optionee's employment agreement with the Company.

Documents

1 file